Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx.

MLA

Gandhi, Shipra, et al. “Systemic Infusion of TLR3-Ligand and IFN-α in Patients with Breast Cancer Reprograms Local Tumor Microenvironments for Selective CTL Influx.” Journal for Immunotherapy of Cancer, vol. 11, no. 11, Nov. 2023. EBSCOhost, https://doi.org/10.1136/jitc-2023-007381.

APA

Gandhi, S., Opyrchal, M., Grimm, M. J., Slomba, R. T., Kokolus, K. M., Witkiewicz, A., Attwood, K., Groman, A., Williams, L., Tarquini, M. L., Wallace, P. K., Soh, K. T., Minderman, H., Maguire, O., O’Connor, T. L., Early, A. P., Levine, E. G., & Kalinski, P. (2023). Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx. Journal for Immunotherapy of Cancer, 11(11). https://doi.org/10.1136/jitc-2023-007381

Chicago

Gandhi, Shipra, Mateusz Opyrchal, Melissa J Grimm, Ronald T Slomba, Kathleen M Kokolus, Agnieszka Witkiewicz, Kristopher Attwood, et al. 2023. “Systemic Infusion of TLR3-Ligand and IFN-α in Patients with Breast Cancer Reprograms Local Tumor Microenvironments for Selective CTL Influx.” Journal for Immunotherapy of Cancer 11 (11). doi:10.1136/jitc-2023-007381.